Virtus ETF Advisers’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,972
| Closed | -$69.2K | – | 628 |
|
|
2024
Q4 | $69.2K | Buy |
2,972
+124
| +4% | +$2.89K | 0.03% | 382 |
|
|
2024
Q3 | $83.8K | Buy |
2,848
+51
| +2% | +$1.5K | 0.04% | 407 |
|
|
2024
Q2 | $65.8K | Sell |
2,797
-3,041
| -52% | -$71.5K | 0.03% | 438 |
|
|
2024
Q1 | $221K | Sell |
5,838
-401
| -6% | -$15.2K | 0.12% | 236 |
|
|
2023
Q4 | $134K | Buy |
+6,239
| New | +$134K | 0.09% | 317 |
|